Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             35 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A combined liquid Hib (PRP-OMP), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: uncontrolled preliminary clinical trial of immunogenicity and reactogenicity Nolan, Terry
1998
16 20 p. 2085-2089
5 p.
artikel
2 A model to estimate the potential economic benefits of measles eradication for the United States Miller, Mark A.
1998
16 20 p. 1917-1922
6 p.
artikel
3 Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines Eyles, Jim E.
1998
16 20 p. 2000-2009
10 p.
artikel
4 Anti-haemolysin IgG1 to IgG2 ratios correlate with haemolysin neutralization titres and lung lesion scores in Actinobacillus pleuropneumoniae infected pigs Furesz, S.E
1998
16 20 p. 1971-1975
5 p.
artikel
5 A search for serologic correlates of immunity to Bordetella pertussis cough illnesses Cherry, James D
1998
16 20 p. 1901-1906
6 p.
artikel
6 Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age Arístegui, Javier
1998
16 20 p. 1976-1981
6 p.
artikel
7 Delayed progression of murine AIDS in C57BL 6 mice pre-immunized with a highly antigenic 10-mer peptide encoded by the murine AIDS defective virus gag p12 gene Mizuochi, Toshiaki
1998
16 20 p. 2026-2030
5 p.
artikel
8 Duration of serum antibody responses following vaccination and revaccination of cattle with non-living commercial Pasteurella haemolytica vaccines Confer, A.W
1998
16 20 p. 1962-1970
9 p.
artikel
9 Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A Thompson, H.S.G
1998
16 20 p. 1993-1999
7 p.
artikel
10 Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine Koike, Yuko
1998
16 20 p. 1982-1989
8 p.
artikel
11 Fluorescence spectroscopy monitoring of the conformational restraint of formaldehyde- and glutaraldehyde- treated infectious bursal disease virus proteins Cepica, Arnost
1998
16 20 p. 1957-1961
5 p.
artikel
12 Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells — effects of passage in cell culture and the human gastrointestinal tract Chezzi, C.
1998
16 20 p. 2031-2038
8 p.
artikel
13 Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis Swartz, Tiberio Alex
1998
16 20 p. 2090-2095
6 p.
artikel
14 Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers Kumar, Mary L.
1998
16 20 p. 2047-2051
5 p.
artikel
15 Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response Rodriguez, María E.
1998
16 20 p. 1941-1949
9 p.
artikel
16 Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use Deliyannis, Georgia
1998
16 20 p. 2058-2068
11 p.
artikel
17 Inducing cytoxic T-lymphocyte response to HIV; recombinant vaccinia virus expressing HIV virus gp160 for use as a recombinant vaccine 1998
16 20 p. 2097-
1 p.
artikel
18 Induction of HIV-1 IIIb neutralizing antibodies in BALB c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV Fernández, I.M
1998
16 20 p. 1936-1940
5 p.
artikel
19 Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis Storsaeter, Jann
1998
16 20 p. 1907-1916
10 p.
artikel
20 Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results Van Herck, Koen
1998
16 20 p. 1933-1935
3 p.
artikel
21 Musosal immunoadjuvant activity of recombinant Escherichia coli heatlabile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen Verweij, Willem R
1998
16 20 p. 2069-2076
8 p.
artikel
22 New lymphocyte stimulating factor which stimulates release of interferon-gamma from CD8 cells; for use in African sleeping sickness recombinant vaccine 1998
16 20 p. 2097-
1 p.
artikel
23 New population of dendritic cell precursors with CD34Io, CD123hi phenotype; dendrite cell culture for use as vaccine 1998
16 20 p. 2097-
1 p.
artikel
24 Oral administration of polymer-grafted starch microparticles activates gut-associated lymphocytes and primes mice for a subsequent systemic antigen challenge Heritage, Philippa L.
1998
16 20 p. 2010-2017
8 p.
artikel
25 Protection against Boophilus annulatus infestations in cattle vaccinated with the B. microplus Bm86-containing vaccine Gavac Fragoso, H.
1998
16 20 p. 1990-1992
3 p.
artikel
26 Serological correlates of immunity to Bordetella pertussis Hewlett, E.L.
1998
16 20 p. 1899-1900
2 p.
artikel
27 Serologic responses of young colostrum fed dairy calves to antigens of Pasteurella haemolytica A1 Hodgins, Douglas C.
1998
16 20 p. 2018-2025
8 p.
artikel
28 Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin Hotomi, Muneki
1998
16 20 p. 1950-1956
7 p.
artikel
29 Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice Jabbal-Gill, Inderjit
1998
16 20 p. 2039-2046
8 p.
artikel
30 The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccines Fine, Paul E.M.
1998
16 20 p. 1923-1928
6 p.
artikel
31 The plea against annual influenza vaccination? ‘The Hoskins' Paradox’ revisited Beyer, W.E.P.
1998
16 20 p. 1929-1932
4 p.
artikel
32 Use of cytomegalovirus genes UBattelleS3 or US6; for use as recombinant vaccine or in immunosuppressive gene therapy 1998
16 20 p. 2097-
1 p.
artikel
33 Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection Sjölander, Anders
1998
16 20 p. 2077-2084
8 p.
artikel
34 Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts Davidkin, Irja
1998
16 20 p. 2052-2057
6 p.
artikel
35 Vector construct directing expression of an intracellular pathogenic antigen; HIV virus, FIV virus, hepatitis B virus and hepatitis C virus for use in gene therapy and as a recombinant vaccine against bacterium and virus infection 1998
16 20 p. 2097-
1 p.
artikel
                             35 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland